Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early treatment versus expectant management for PDA in extremely preterm infants
NL-OMON47250Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of ibuprofen and indomethacin in patent ductus arteriosus (PDA) (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Primary composite endpoint. Started Dec 2016; status: active, not recruiting.
02
Drugs
ibuprofenindomethacin
03
Conditions
patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on NL-OMON47250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47250.